Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies
- PMID: 32205339
- PMCID: PMC7204797
- DOI: 10.1136/esmoopen-2019-000618
Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies
Abstract
Patients with cancer are subjected to several imaging examinations which frequently require the administration of contrast medium (CM). However, it has been estimated that acute kidney injury (AKI) due to the injection of iodinated CM accounts for 11% of all cases of AKI, and it is reported in up to 2% of all CT examinations. Remarkably, the risks of developing AKI are increased in the elderly, in patients with chronic kidney disease or diabetes, and with dehydration or administration of nephrotoxic chemotherapeutics. Given the common occurrence of postcontrast acute kidney injury (PC-AKI) in clinical practice, primary care physicians and all specialists involved in managing patients with cancer should be aware of the strategies to reduce the risk of this event. In 2018, a panel of four experts from the specialties of radiology, oncology and nephrology were speakers at the annual meeting of the Italian Society of Medical Radiology (Società Italiana di Radiologia Medica e Interventistica), with the aim of commenting on existing evidence and providing their experience on the incidence and management of PC-AKI in patients with cancer. The discussion represented the basis for this white paper, which is intended to be a practical guide organised by statements describing methods to reduce renal injury risks related to CM-enhanced CT examinations in patients with cancer.
Keywords: acute renal injury; cancer; contrast medium.
© Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.
Conflict of interest statement
Competing interests: LG, CPo, LC and AL acted as speakers and/or consultants for GE Healthcare. GE Healthcare supported the meeting, which led to this paper.
Figures
References
-
- American Cancer Society Cancer treatment and survivorship facts and figures 2016–2017. Atlanta: American Cancer Society, 2016.
-
- Del Mastro L, Laghi A, Ronco C. Methods to address computed tomography-related risk factors in oncology patients: an expert opinion based on current evidence. Blood Purif 2018;46:56–69. 10.1159/000486821 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
